Glucotrack (GCTK) Net Cash Flow Growth (3y) (2013 - 2025)
Glucotrack (GCTK) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.59 Bn | 121.37 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | -55.30% |
| 3 | Alcon | 32.93 Bn | 31.27 Bn | 1.53 Bn | 39.87% |
| 4 | Medline | 32.81 Bn | 30.58 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.39 Bn | 27.73 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 23.40 Bn | 22.97 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 14.07 Bn | 13.51 Bn | 1.10 Bn | -159.90% |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | 78.59% |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | 36.49% |
| 10 | Glucotrack | 182,663.74 | -7.20 Mn | - | 20.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.94% |
| Sep 30, 2025 | -40.71% |
| Jun 30, 2025 | 34.89% |
| Mar 31, 2025 | 67.80% |
| Dec 31, 2024 | 94.94% |
| Sep 30, 2024 | 30.63% |
| Jun 30, 2024 | -25.58% |
| Mar 31, 2024 | -47.61% |
| Dec 31, 2023 | -41.50% |
| Sep 30, 2023 | -33.17% |
| Jun 30, 2023 | -1.85% |
| Mar 31, 2023 | -28.25% |
| Dec 31, 2022 | -5.44% |
| Sep 30, 2022 | 17.28% |
| Jun 30, 2022 | -34.12% |
| Mar 31, 2022 | -160.83% |
| Dec 31, 2021 | -5.78% |
| Sep 30, 2021 | -43.85% |
| Jun 30, 2021 | -48.56% |
| Mar 31, 2021 | -76.05% |